STAT

OCTOBER 23, 2023

The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA (..)

Vaccines 364

Vaccines Immunity Immunization 364

STAT

AUGUST 23, 2023

Of the 103 million confirmed cases of Covid-19 in the U.S., an estimated one-third have led to long Covid — a condition that ranges in severity, but can be debilitating. A new study suggests that even more people may be suffering from the post-viral syndrome without having ever received an official diagnosis of Covid-19.

246

246

STAT

OCTOBER 4, 2023

It’s the end of an era for a once-critical pandemic document: The ubiquitous white Covid-19 vaccination cards are being phased out. Now that Covid-19 vaccines are not being distributed by the federal government, the Centers for Disease Control and Prevention has stopped printing new cards. Read the rest…

Vaccines 306

Vaccines Documentation 306

STAT

JULY 31, 2023

When the Covid-19 pandemic began in 2020, some experts assumed the virus would affect everyone even-handedly, regardless of their race or socioeconomic background. But the reality of Covid proved to be far from the “great equalizer” — Black and brown communities had higher rates of infection and death.

246

246

STAT

SEPTEMBER 6, 2023

South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the government to pay more than the European Union but offered little protection against delivery failures, according to an advocacy group. Meanwhile, the Serum Institute of India planned to charge South Africa $5.35

Vaccines 355

Vaccines Drug Pricing 355

Pharmaceutical Technology

MAY 8, 2024

AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.

Vaccines 116

Vaccines 116

STAT

SEPTEMBER 28, 2023

WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose. And it’s paying more than countries that did far less to support vaccine development.

Vaccines 364

Vaccines 364

STAT

SEPTEMBER 27, 2022

Gavin Newsom that strengthens discipline for doctors who knowingly spread Covid-19 misinformation. More than two years into the pandemic, Covid-19 misinformation still runs rampant. Legislation like this is sorely needed across the country.

Vaccines 364

Vaccines Immunity Immunization 364

STAT

FEBRUARY 15, 2023

In an unexpected shift, Moderna has decided not to ask Americans to pay for its Covid-19 vaccine, a move that follows intense criticism over initial plans to charge $110 to $130 per dose after the company pivots from government contracts to commercial distribution. “Everyone in the U.S.

Vaccines 364

Vaccines 364

STAT

DECEMBER 22, 2022

Covid-19 made things worse. The early signs and symptoms of sepsis mimic those of both Covid-19 and influenza: fever, chills, dry cough, shortness of breath, fatigue, muscle or body aches, sore throat, nasal congestion, runny nose, and more.

Immunity 321

Immunity Immunization Drug Development 321

STAT

FEBRUARY 2, 2023

China’s massive Covid-19 crisis, sparked in part by the country’s rolling back its strict zero-Covid policies in early December, has seen millions of people infected with SARS-CoV-2.

252

252

STAT

JULY 25, 2023

A hearing began in a South Africa court on Tuesday to determine whether the government overpaid for Covid-19 vaccines, an allegation made by advocacy groups who contend that a lack of transparency may have masked pharmaceutical profits at the public’s expense. The contracts, however, have never been publicly disclosed.

Vaccines 246

Vaccines Drug Pricing 246

STAT

NOVEMBER 4, 2022

New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4

Vaccines 345

Vaccines Immunity Immunization 345

STAT

NOVEMBER 3, 2022

The journal Nature published today global consensus recommendations to end Covid-19 as a public health threat. There have been times when we wondered if it was worth the effort.

345

345

STAT

AUGUST 9, 2023

The new director of the Centers for Disease Control and Prevention, Mandy Cohen , is overhauling the leadership of the CDC center that led the agency’s Covid-19 response.

Immunity 246

Immunity Immunization 246

Pharmafile

MAY 9, 2024

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in global demand. The post AstraZeneca withdraws COVID-19 vaccine Vaxzevria appeared first on Pharmafile.

Vaccines 59

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 59

STAT

NOVEMBER 22, 2022

The updated Covid-19 boosters increase people’s protection against symptomatic infection from the coronavirus, according to some of the first estimates of how the shot is performing in the real world and in people, not just in lab experiments.

Vaccines 343

Vaccines 343

The Pharmacist

APRIL 15, 2024

The NHS national booking system for spring Covid-19 vaccination bookings via pharmacies in England is now open. The […] The post NHS opens national booking system for spring Covid-19 vaccinations appeared first on The Pharmacist. Those eligible to book appointments are able to do so for next week.

Vaccines 109

Vaccines 109

The Guardian - Pharmaceutical Industry

MAY 7, 2024

Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

STAT

DECEMBER 8, 2022

The Food and Drug Administration announced Thursday it had amended the emergency use authorizations for the updated Moderna and Pfizer-BioNTech Covid-19 boosters, to allow their use in children aged 6 months and older.

Vaccines 246

Vaccines 246

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. Moderna acknowledged that this patient population has the greatest risk for severe outcomes from COVID-19. Moderna’s Spikevax XBB.1.5-adapted

Vaccines 95

Vaccines Immunity Immunization 95

STAT

NOVEMBER 7, 2023

WASHINGTON — Current and former government officials proffered a clear-eyed, and often depressing, take Tuesday on the state of clinical trials, the pharmaceutical industry, and biotech investors coming out of the Covid-19 pandemic.

Vaccines 292

Vaccines 292

STAT

SEPTEMBER 1, 2022

An expert committee that advises the Centers for Disease Control and Prevention on vaccine policy voted on Thursday to recommend use of updated Covid-19 vaccines. With the positive votes from the Advisory Committee on Immunization Practices, the issue now goes to CDC Director Rochelle Walensky.

Vaccines 246

Vaccines Immunity Immunization 246

The Pharmacist

FEBRUARY 5, 2024

Pharmacies currently providing the Covid-19 vaccine are being asked by NHS England (NHSE) to extend their service provision contracts until 31 August 2024. While the fee for the extension period remains at […] The post Covid-19 vaccine contract extensions to carry added spring payment appeared first on The Pharmacist.

Vaccines 118

Vaccines 118

The Pharmacist

SEPTEMBER 8, 2023

The Pharmacists’ Defence Association (PDA) has urged pharmacists to ask their employers to sign the Covid-19 safety pledge, which includes a commitment to ensuring that all workers who test positive for the virus are both asked to self-isolate and given adequate support to stay at home.

129

129

European Pharmaceutical Review

MAY 9, 2024

Withdrawal of the marketing authorisation for the COVID-19 vaccine (ChAdOx1-S [recombinant]) Vaxzevria (SRD) by the European Medicines Agency on 7 May, follows a request by AstraZeneca. Global demand for all COVID vaccines is now much lower and overall supply exceeds demand.

Vaccines 76

Vaccines 76

The Pharmacist

SEPTEMBER 29, 2023

Excluding pharmacists from benefits available to healthcare workers during the pandemic was ‘shocking’ and ‘disappointing’, sector representatives have told the national Covid-19 public inquiry.

114

114

European Pharmaceutical Review

AUGUST 2, 2023

A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). MHRA authorisation of Bimervax The COVID-19 vaccine, developed by HIPRA Human Health, combines a part of the SARS-CoV-2 virus spike protein with an adjuvant, according to the MHRA.

Vaccines 98

Vaccines Immunity Immunization 98

Pharmafile

APRIL 9, 2024

Gilead Sciences has announced that the National Institute of Health and Care Excellence (NICE) has recommended the use of Veklury (remdesivir) for the treatment of COVID-19 in eligible adults and children.

59

59

World Pharma News

APRIL 23, 2024

Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.

61

61

pharmaphorum

DECEMBER 6, 2023

Protecting the immunocompromised: Preventative measures against COVID-19 Mike.Hammerton Wed, 06/12/2023 - 12:15 Bookmark this

113

113

European Pharmaceutical Review

NOVEMBER 1, 2023

adapted COVID-19 vaccine, developed by Novavax for this autumn and winter season. is to be used for preventing COVID-19 in adults and children from 12 years of age. Approval of the only updated protein-based non-mRNA COVID-19 vaccine in the EU is an important milestone as the need for vaccination continues,” said John C.

Vaccines 101

Vaccines Immunity Immunization 101

Outsourcing Pharma

FEBRUARY 13, 2024

Japanese pharmaceutical company Shionogi has announced the first peer-reviewed publication of its phase 3 study investigating ensitrelvir to treat patients with mild to moderate COVID-19 in Japan, South Korea and Vietnam.

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies 109

European Pharmaceutical Review

MARCH 9, 2023

A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. The investigators noted that this nasally- delivered treatment differs to other monoclonal antibodies used to treat COVID-19.

Immunity 145

Immunity Immunization Medical Schools Hospitals 145

Pharmaceutical Technology

APRIL 19, 2024

Following the success of the COVID-19 vaccines, there has been an increasing focus on mRNA’s potential to address a wide range of diseases, including cancer.

Vaccines 59

Vaccines 59

Pharmaceutical Technology

NOVEMBER 29, 2023

Japan’s MHLW has approved CSL and Arcturus Therapeutics’ self-amplifying mRNA (sa-mRNA) Covid-19 vaccine, ARCT-154.

Vaccines 124

Vaccines 124

Express Pharma

SEPTEMBER 6, 2023

UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted Pfizer/BioNTech COVID-19 vaccine that targets the Omicron XBB 1.5 The post MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5 The vaccine has been approved for use in individuals from six months of age.

Vaccines 102

Vaccines Immunity Immunization 102